Y-Intercept (HK)’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Buy
15,157
+1,182
+8% +$20.3K ﹤0.01% 1467
2026
Q2
$298K Buy
+13,975
New +$263K 0.01% 1468
2023
Q2
– Sell
-4,443
Closed -$279K – 1742
2023
Q1
$279K Buy
+4,443
New +$265K 0.03% 813

Other funds holding USNA

Y-Intercept (HK)'s USNA Position: Q3 2026 in Review

Y-Intercept (HK) increased its Usana Health Sciences (USNA) stake by 8.5% in Q3 2026, buying an estimated $20.3K and bringing the position to 15,157 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Y-Intercept (HK) first reported a position in USNA in Q1 2023 and has held it in 3 quarters since. The position peaked at $298K in Q2 2026. 15 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Y-Intercept (HK) held 15,157 shares of Usana Health Sciences worth $219K as of Q3 2026.
  • Y-Intercept (HK) bought 1,182 Usana Health Sciences shares in Q3 2026, an estimated $20.3K.
  • Usana Health Sciences made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1467 holding.
  • Y-Intercept (HK) first reported a position in Usana Health Sciences in Q1 2023 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Usana Health Sciences position peaked at $298K in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.